Logan Capital Management Inc Astrazeneca PLC Transaction History

Logan Capital Management Inc

$2.24 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $2.64 Million - $2.86 Million	-37,733 Reduced 99.96%	15 $1,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $14,713 - $16,682	233 Added 0.62%	37,748 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $77,953 - $101,292	1,438 Added 3.99%	37,515 $2.54 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $225,016 - $576,123	-4,244 Reduced 10.53%	36,077 $1.98 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $305,485 - $366,726	5,155 Added 14.66%	40,321 $2.66 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $282,556 - $340,365	5,071 Added 16.85%	35,166 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $108,472 - $128,170	2,008 Added 7.15%	30,095 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $18,001 - $19,695	324 Added 1.17%	28,087 $1.69 Million
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $152,280 - $189,266	3,145 Added 12.78%	27,763 $1.66 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $21,033 - $24,280	446 Added 1.85%	24,618 $1.23 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $21,348 - $25,528	-440 Reduced 1.79%	24,172 $1.21 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $78,012 - $89,817	1,470 Added 6.35%	24,612 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $36,635 - $47,013	850 Added 3.81%	23,142 $1.22 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $113,370 - $153,990	-3,000 Reduced 11.86%	22,292 $996,000
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $14,266 - $16,954	336 Added 1.35%	25,292 $1.26 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $46,378 - $52,563	-1,156 Reduced 4.43%	24,956 $1.11 Million
Q2 2019 Jul 24, 2019	BUY	$37.28 - $41.68 $43,207 - $48,307	1,159 Added 4.64%	26,112 $1.08 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $76,090 - $92,234	-2,144 Reduced 7.91%	24,953 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $77,258 - $86,963	2,096 Added 8.38%	27,097 $1.03 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $23,358 - $26,691	-672 Reduced 2.62%	25,001 $990,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $32,027 - $34,345	927 Added 3.75%	25,673 $901,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $42,663 - $47,399	-1,294 Reduced 4.97%	24,746 $866,000
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $54,873 - $59,473	1,710 Added 7.03%	26,040 $904,000
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $58,006 - $68,102	2,003 Added 8.97%	24,330 $824,000
Q2 2017 Aug 14, 2017	BUY	N/A	22,327	22,327 $761,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$4.88 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.2 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.05 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.76 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.32 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account